======= C1orf109 =======
== Gene Information ==
* **Official Symbol**: C1orf109
* **Official Name**: chromosome 1 open reading frame 109
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54955|54955]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NX04|Q9NX04]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=C1orf109&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C1orf109|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May promote cancer cell proliferation by controlling the G1 to S phase transition. {ECO:0000269|PubMed:22548824}.
No Pfam Domain information is available for this gene.
No GO term information is available for this gene.
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp280|Daidzin 10μM R06 exp280]]|-2.1|
|[[:results:exp100|NFN1 1μM R03 exp100]]|-2.09|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 738/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|26/26|
|breast|33/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|74/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 892
* **Expression level (log2 read counts)**: 5.15
{{:chemogenomics:nalm6 dist.png?nolink |}}